Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 29, 2024Annals of HematologyOpen Access

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study

View Full Paper
Ask AI
Bookmark
Share

Authors

CJCarlos Jiménez‐VicenteHospital Clínic de BarcelonaAGAres Guardia-TorrellesHospital Clínic de BarcelonaAPAmanda Isabel Pérez‐ValenciaHospital Clínic de Barcelona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jiménez‐Vicente et al. (2024) studied this question.

synapsesocial.com/papers/68e5a5efb6db643587540299https://doi.org/10.1007/s00277-024-05923-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1How I treat acute myeloid leukemia in the era of new drugs2019 · 308 citations
  2. 2International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data2022 · 2,933 citations
  3. 3Venetoclax combined with <scp>FLAG‐IDA</scp> induction and consolidation in newly diagnosed acute myeloid leukemia2022 · 98 citations
  4. 4Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents2019 · 84 citations
  5. 5Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia2018 · 939 citations